In a case involving a 21‐month‐old patient, biallelic mutations in the ATP13A3 gene were linked to malignant progression of PAH, prompting a high‐risk Potts shunt procedure [58]. This evidence concerns the gene ATP13A3 and pulmonary arterial hypertension.